Dec 2, 2025 · Tirzepatide (Zepbound brand) is a once-weekly injection used for weight loss, weight management, and weight-related conditions, including obstructive sleep apnea (OSA).

Dec 1, 2025 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzepatide is a glucose-dependent insulinotropic …

This site provides information about Mounjaro ® (tirzepatide) and Zepbound ® (tirzepatide), our prescription-only, FDA-approved medicines containing tirzepatide.

Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. [10] The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper …

Tirzepatide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.

Mounjaro (tirzepatide) helps manage blood sugar in people with Type 2 diabetes. It also helps with weight loss. It’s an injection you take once every seven days.

Nov 13, 2025 · Tirzepatide, marketed as Mounjaro and recently also as Zepbound specifically for weight management, was approved for type 2 diabetes in 2022 and for weight management in 2023.

May 11, 2025 · Therefore, we conducted a 72-week, randomized, controlled trial to evaluate the efficacy and safety of the maximum tolerated dose of tirzepatide (10 mg or 15 mg) as compared with the …

Jan 13, 2025 · Tirzepatide is a prescription medication indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dec 27, 2024 · Find patient medical information for Zepbound (tirzepatide) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings